SUSVIMO™ Ranibizumab 10 mg / mL Injection .01 mL

Name: Vascular endothelial growth factor (VEGF-A) inhibitor
Brand: SUSVIMO™

SUSVIMO, IMPLANT INJ W/FILL NDL 100MG/ML (1/CT)

McKesson #

1259169

Manufacturer #

50242007855

Brand

SUSVIMO™

Manufacturer

Genentech USA Inc

Country of Origin

Unknown

Application

Vascular endothelial growth factor (VEGF-A) inhibitor

Container Type

Single-Dose Vial

Dosage Form

Injection

Generic Drug Name

Ranibizumab

NDC Number

50242007855

Product Dating

McKesson Acceptable Dating: we will ship >= 180 days

Storage Requirements

Requires Refrigeration

Strength

10 mg / mL

Type

Intravitreal

UNSPSC Code

42294544

Volume

.01 mL

Attention Customer: Please note that this product needs to be ordered alongside the Susvimo, Implant w/ Insertion Tool, MMS # 1258932/ CTLG 00810042590052 for administration
SUSVIMO™ (ranibizumab injection) for intravitreal use via SUSVIMO ocular implant
SUSVIMO (ranibizumab injection), a vascular endothelial growth factor (VEGF) inhibitor, is indicated for the treatment of patients with Neovascular (wet) Age-related Macular Degeneration (AMD) who have previously responded to at least two intravitreal injections of a VEGF inhibitor
Each SUSVIMO initial fill needle kit contains: One SUSVIMO 100 mg / mL single-dose glass vial, and One SUSVIMO initial fill needle (34-gauge needle with a 5 μm integrated filter) with a blue cap
If a return is needed on this product, please contact the manufacturer directly at 800-551-2231
Please see the How To Return Flyer for how to request a return